Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.
The Second World Congress on Targeting Extracellular Vesicles (EVs) is scheduled for 15–16 October 2025 in Valencia, Spain.
1d
Nobel medicine prize: how a hidden army in your body keeps you alive – and could help treat cancer
By learning to adjust these biological “brakes” with precision, medicine is entering a new era. Treatments inspired by these ...
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...
Friendships, family, and community links may support healthier aging by lowering inflammation and slowing biological decline, ...
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...
Are you prepared to live a longer and healthier life? Discover practical ways to improve wellness, extend longevity, and embrace habits that support vitality every day.
Trump’s war on autism: how dangerous and demeaning are his claims? - Trump’s assertions about autism have left scientists and ...
Researchers at Case Western Reserve University identified for the first time how HIV enters a dormant state in infected cells that allows the virus to “hide” from the immune system and current ...
For millennia, aging has been viewed as an immutable, inevitable decline. However, a scientific revolution is underway, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback